Scholars@Duke publication: Tumor-mediated Modulation of Immunometabolism as a Mechanism of Immunotherapy Resistance

Tumor-mediated Modulation of Immunometabolism as a Mechanism of Immunotherapy Resistance

Publication , Conference

Hanks, BA

Duke Scholars

Author Brent A. Hanks Medicine, Medical Oncology

Location

Boston, MA

Conference Name

Immuno-Oncology Summit

Citation

APA

Chicago

ICMJE

MLA

NLM

Hanks, B. A. (n.d.). Tumor-mediated Modulation of Immunometabolism as a Mechanism of Immunotherapy Resistance. Presented at the Immuno-Oncology Summit, Boston, MA.

Hanks, B. A. “Tumor-mediated Modulation of Immunometabolism as a Mechanism of Immunotherapy Resistance,” n.d.

Hanks BA. Tumor-mediated Modulation of Immunometabolism as a Mechanism of Immunotherapy Resistance. In.

Hanks, B. A. Tumor-mediated Modulation of Immunometabolism as a Mechanism of Immunotherapy Resistance.

Hanks BA. Tumor-mediated Modulation of Immunometabolism as a Mechanism of Immunotherapy Resistance.

Location

Boston, MA

Conference Name

Immuno-Oncology Summit